IP Library Granted Patent US 12,053,271
Granted Patent B2
US 12,053,271 · App. 17/030,533 · Granted Aug 6, 2024

Electromechanical pill device with localization capabilities

Inventors: Mitchell Lawrence Jones (La Jolla, CA); Alain Labbé (St. Philippe, CA); Mark Sasha Orlik (Victoria, CA); Christian Terry Proch McMechan (Victoria, CA)
Assignee: BIORA THERAPEUTICS, INC.
A61B5/065A61B1/041A61B5/002A61B5/0086A61B5/073A61B5/6861A61B5/7264H04B10/1143H04B13/00A61B5/0017A61B2560/0443A61B2560/0462A61B2562/162
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,053,271
App. No.
17/030,533
Granted
Aug 6, 2024
Kind
B2
Abstract

Various embodiments are described herein for a device, system, and method for identifying a location of an ingestible device within a gastrointestinal tract of a body. In some embodiments, the ingestible device includes a sensing unit with an axial optical sensing sub-unit located proximal to at least one end of the device, and a radial optical sensing sub-unit located proximal to a radial wall of the device, and may autonomously identify a location within the gastrointestinal tract. In some embodiments, the ingestible device includes optical illumination sources and detectors that operate at a plurality of different wavelengths, and may discern regions of a gastrointestinal tract by using the reflection properties of organ tissue and occasional particulates. In some embodiments, the ingestible device may sample fluid or release medicament based on a detected device location.

Claims (52)

1. An ingestible device, comprising:

a housing, comprising:

a chamber configured to store a therapeutic agent;

an actuator having a first state in which the therapeutic agent is stored in the chamber and a second state in which the therapeutic agent is released from the chamber to an exterior of the housing; and

a detector configured to detect a location of the ingestible device in a GI tract of a subject; and

a microcontroller configured to, based on the location of the ingestible device in the GI tract of the subject detected by the detector, cause the actuator to move from its first state to its second state so that the therapeutic agent is delivered to the exterior of the ingestible device,

one or more sensing sub-units, wherein:

the one or more sensing sub-units comprise the detector; and

the one or more sensing are configured to:

transmit a first wavelength of light towards an environment external to the housing;

for each iteration of transmitting the first wavelength of light, detect the first wavelength of light after it has reflected from the environment external to the housing;

transmit a second wavelength of light towards the environment external to the housing, the second wavelength being different from the first wavelength; and

for each iteration of transmitting the second wavelength of light, detect the second wavelength of light after it has reflected from the environment external to the housing,

wherein the microprocessor is configured to:

generate a first data set comprising a plurality of first values, wherein each first value is indicative of an amount of light detected by the device at the first wavelength for a corresponding iteration detecting the first wavelength of light after it has reflected from the environment external to the housing,

generate a second data set comprising a plurality of second values, wherein each second value is indicative of an amount of light detected by the device at the second wavelength for a corresponding iteration of detecting the second wavelength of light after it has reflected from the environment external to the housing, and

determine a change in a location of the ingestible device within the GI tract of the subject by comparing the first data set to the second data set.

2. The ingestible device of claim 1 , further comprising a light source configured to transmit a first wavelength of light toward an environment external to the housing.

3. The ingestible device of claim 2 , wherein the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum.

4. The ingestible device of claim 2 , wherein the light source is configured to transmit a second wavelength of light toward an environment external to the housing, and the second wavelength is different from the first wavelength.

5. The ingestible device of claim 4 , wherein:

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum; and

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum.

6. The ingestible device of claim 2 , wherein the light source comprises a light emitting diode.

7. The ingestible device of claim 2 , wherein the light source comprises a RGB diode package.

8. The ingestible device of claim 1 , wherein the detector comprises an array of detectors.

9. An ingestible device, comprising:

a housing, comprising:

a chamber;

a member having a first state that does not allow a sample from an exterior of the housing to enter the chamber and a second state that allows a sample to enter the chamber; and

a detector configured to detect a location of the ingestible device in a GI tract of a subject; and

a microcontroller configured to, based on the location of the ingestible device in the GI tract of the subject detected by the detector, cause the member to move from its first state to its second state so that a sample can move from the exterior of the housing into the chamber,

one or more sensing sub-units, wherein:

the one or more sensing sub-units comprise the detector; and

the one or more sensing are configured to:

transmit a first wavelength of light towards an environment external to the housing;

for each iteration of transmitting the first wavelength of light, detect the first wavelength of light after it has reflected from the environment external to the housing;

transmit a second wavelength of light towards the environment external to the housing, the second wavelength being different from the first wavelength; and

for each iteration of transmitting the second wavelength of light, detect the second wavelength of light after it has reflected from the environment external to the housing,

wherein the microprocessor is configured to:

generate a first data set comprising a plurality of first values, wherein each first value is indicative of an amount of light detected by the device at the first wavelength for a corresponding iteration detecting the first wavelength of light after it has reflected from the environment external to the housing,

generate a second data set comprising a plurality of second values, wherein each second value is indicative of an amount of light detected by the device at the second wavelength for a corresponding iteration of detecting the second wavelength of light after it has reflected from the environment external to the housing, and

determine a change in a location of the ingestible device within the GI tract of the subject by comparing the first data set to the second data set.

10. The ingestible device of claim 9 , further comprising a light source configured to transmit a first wavelength of light toward an environment external to the housing.

11. The ingestible device of claim 10 , wherein the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum.

12. The ingestible device of claim 10 , wherein the light source is configured to transmit a second wavelength of light toward an environment external to the housing, and the second wavelength is different from the first wavelength.

13. The ingestible device of claim 12 , wherein:

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum; and

the first wavelength of light is in a spectrum selected from the group consisting of an infrared spectrum, a red spectrum, a blue spectrum and a green spectrum.

14. The ingestible device of claim 10 , wherein the light source comprises a light emitting diode.

15. The ingestible device of claim 10 , wherein the light source comprises a RGB diode package.

16. The ingestible device of claim 9 , wherein the detector comprises an array of detectors.

Assignments (8)
SECURITY INTEREST Recorded Aug 15, 2025
From: BT BIDCO, INC.
To: GLAS USA LLC
Reel/Frame 072473/0861 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO, INC.
Reel/Frame 070585/0061 →
LIEN Recorded Mar 18, 2025
From: BIORA THERAPEUTICS, INC.
To: BT BIDCO LLC
Reel/Frame 070552/0366 →
SECURITY INTEREST Recorded Dec 21, 2023
From: BIORA THERAPEUTICS, INC.
To: GLAS TRUST COMPANY LLC, AS COLLATERAL AGENT
Reel/Frame 066089/0235 →
CHANGE OF NAME Recorded Apr 28, 2022
From: PROGENITY, INC.
To: BIORA THERAPEUTICS, INC.
Reel/Frame 059820/0076 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2020
From: INTERFACE THERAPEUTICS, INC.
To: PROGENITY INC.
Reel/Frame 053958/0581 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2020
From: MICROPHARMA LIMITED
To: INTERFACE THERAPEUTICS, INC.
Reel/Frame 053958/0494 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 2, 2020
From: JONES, MITCHELL LAWRENCE; LABBE, ALAIN; DRLIK, MARK SASHA; MCMECHAN, CHRISTIAN TERRY
To: MICROPHARMA LIMITED
Reel/Frame 053958/0382 →
Continuity (3)
Continuation 15514413
Provisional Application 62055244 · Sep 25, 2014
Related Publication 20210015398A1 · Jan 21, 2021